rs2288474

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_054027.6(ANKH):​c.963A>G​(p.Ala321Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0528 in 1,613,956 control chromosomes in the GnomAD database, including 3,130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 420 hom., cov: 33)
Exomes 𝑓: 0.052 ( 2710 hom. )

Consequence

ANKH
NM_054027.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -4.92

Publications

17 publications found
Variant links:
Genes affected
ANKH (HGNC:15492): (ANKH inorganic pyrophosphate transport regulator) This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]
ANKH Gene-Disease associations (from GenCC):
  • chondrocalcinosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • craniometaphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • skeletal dysplasia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • craniometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-14741875-T-C is Benign according to our data. Variant chr5-14741875-T-C is described in ClinVar as Benign. ClinVar VariationId is 351512.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.92 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKHNM_054027.6 linkc.963A>G p.Ala321Ala synonymous_variant Exon 8 of 12 ENST00000284268.8 NP_473368.1 Q9HCJ1-1
ANKHXM_017009644.3 linkc.879A>G p.Ala293Ala synonymous_variant Exon 8 of 12 XP_016865133.1
ANKHXM_011514067.2 linkc.963A>G p.Ala321Ala synonymous_variant Exon 8 of 9 XP_011512369.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKHENST00000284268.8 linkc.963A>G p.Ala321Ala synonymous_variant Exon 8 of 12 1 NM_054027.6 ENSP00000284268.6 Q9HCJ1-1
ANKHENST00000503939.5 linkn.475A>G non_coding_transcript_exon_variant Exon 5 of 6 3
ANKHENST00000515517.1 linkn.197A>G non_coding_transcript_exon_variant Exon 3 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0636
AC:
9676
AN:
152136
Hom.:
416
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0828
Gnomad AMI
AF:
0.0735
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.0485
Gnomad FIN
AF:
0.0313
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0443
Gnomad OTH
AF:
0.0621
GnomAD2 exomes
AF:
0.0704
AC:
17709
AN:
251412
AF XY:
0.0647
show subpopulations
Gnomad AFR exome
AF:
0.0811
Gnomad AMR exome
AF:
0.182
Gnomad ASJ exome
AF:
0.0270
Gnomad EAS exome
AF:
0.117
Gnomad FIN exome
AF:
0.0324
Gnomad NFE exome
AF:
0.0444
Gnomad OTH exome
AF:
0.0525
GnomAD4 exome
AF:
0.0516
AC:
75462
AN:
1461702
Hom.:
2710
Cov.:
31
AF XY:
0.0511
AC XY:
37153
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.0799
AC:
2674
AN:
33474
American (AMR)
AF:
0.175
AC:
7809
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0246
AC:
644
AN:
26132
East Asian (EAS)
AF:
0.146
AC:
5789
AN:
39694
South Asian (SAS)
AF:
0.0506
AC:
4365
AN:
86248
European-Finnish (FIN)
AF:
0.0344
AC:
1839
AN:
53412
Middle Eastern (MID)
AF:
0.0340
AC:
196
AN:
5768
European-Non Finnish (NFE)
AF:
0.0442
AC:
49109
AN:
1111878
Other (OTH)
AF:
0.0503
AC:
3037
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3490
6979
10469
13958
17448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1972
3944
5916
7888
9860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0637
AC:
9697
AN:
152254
Hom.:
420
Cov.:
33
AF XY:
0.0639
AC XY:
4758
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0831
AC:
3450
AN:
41538
American (AMR)
AF:
0.115
AC:
1756
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
68
AN:
3472
East Asian (EAS)
AF:
0.123
AC:
638
AN:
5174
South Asian (SAS)
AF:
0.0485
AC:
234
AN:
4824
European-Finnish (FIN)
AF:
0.0313
AC:
332
AN:
10620
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0443
AC:
3013
AN:
68014
Other (OTH)
AF:
0.0620
AC:
131
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
445
891
1336
1782
2227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0510
Hom.:
402
Bravo
AF:
0.0725
Asia WGS
AF:
0.0850
AC:
293
AN:
3478
EpiCase
AF:
0.0419
EpiControl
AF:
0.0382

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Craniometaphyseal dysplasia, autosomal dominant Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Chondrocalcinosis 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.080
DANN
Benign
0.40
PhyloP100
-4.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288474; hg19: chr5-14741984; COSMIC: COSV52478555; API